Current role
Lorena Lerner, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lorena Lerner, Ph.D.
Keros Therapeutics, Inc. reported in an 8-K filed August 6, 2025 that Lorena Lerner, Ph.D. was appointed Chief Scientific Officer, effective August 6, 2025.
“Lorena Lerner, Ph.D., Senior Vice President, Research, is being promoted to Chief Scientific Officer, effective August 6, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Keros Therapeutics, Inc. (KROS)
SEC 8-K
Current2025-08-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Keros Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Jasbir Seehra CEO, Chairman, Board Member
- Jean-Jacques Bienaimé Chairman, Board Member
- Annita Tanini Chief Accounting Officer
- Alpna Seth Board Member
- Anne Prener, M.D., Ph.D. Board Member
- Charles Newton Board Member
- Mary Ann Gray Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.